PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jexpmedHomeThe Rockefeller University PressThis articleEditorsContactInstructions for AuthorsThis issue
 
J Exp Med. Nov 22, 2010; 207(12): 2543–2550.
PMCID: PMC2989770
A requirement for Lim domain binding protein 1 in erythropoiesis
LiQi Li,1 Jan Y. Lee,1 Jennifer Gross,1 Sang-Hyun Song,2 Ann Dean,2 and Paul E. Lovecorresponding author1
1Section on Cellular and Developmental Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and 2Laboratory of Cellular and Developmental Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892
corresponding authorCorresponding author.
CORRESPONDENCE Paul E. Love: lovep/at/mail.nih.gov
Received March 12, 2010; Accepted October 1, 2010.
During erythrocyte development, the nuclear cofactor Lim domain binding protein 1 (Ldb1) functions as a core subunit of multiprotein DNA binding complexes that include the transcription factors Scl and Gata-1 and the Lim-only adapter Lmo2. Scl, Gata-1, and Lmo2 are each required for erythropoiesis, suggesting that Ldb1-nucleated transcription complexes regulate key steps during erythropoiesis. We documented a requirement for Ldb1 in erythropoiesis in mice. Analysis of ldb1−/− embryos revealed a critical requirement for Ldb1 during primitive erythropoiesis, and conditional inactivation of ldb1 at later stages of gestation and in adult mice demonstrated that Ldb1 is continuously required for both definitive erythropoiesis and megakaryopoiesis. Down-regulation of Ldb1 in erythroblasts inhibited the expression of multiple erythroid-specific and prosurvival genes. These results represent the first unequivocal demonstration of a role for Ldb1 in erythropoiesis in vivo and establish a critical function for Ldb1-nucleated complexes in regulating the erythroid/megakaryocyte transcriptional program.
Erythropoiesis follows a stepwise differentiation process that involves the commitment of hematopoietic stem cells (HSCs) to lineage-restricted progenitors and to terminally differentiated red blood cells. The first wave of erythropoiesis, designated primitive erythropoiesis, is transient and begins around embryonic day (E) 7.5 in the mouse extraembryonic yolk sac and/or aorta-gonad-mesonephros (Palis et al., 1999; Baumann and Dragon, 2005). Primitive erythrocytes (EryPs) represent the predominant blood cells in circulation until E12, when a second wave of erythroblasts generated in the fetal liver gives rise to definitive adult-type erythrocytes.
Erythropoiesis is critically dependent on the activity of the zinc finger transcription factor Gata-1 which is required for the expression of erythroid-specific genes (Welch et al., 2004). Gata-1 binds to several different cofactors, including Fog, Runx1, PU.1 EKLF, Lmo2, and SP1, and can function as both a transcriptional activator and a transcriptional repressor (Wadman et al., 1997; Johnson et al., 2007; Kim and Bresnick, 2007; Tripic et al., 2009). Multi-subunit complexes containing Gata-1 in addition to the basic helix-loop-helix transcription factors Scl/Tal1 and E2A and the nuclear adapters Lmo2 and Lim domain binding protein 1 (Ldb1) have also been described in erythroid cell lines (Wadman et al., 1997). These multimeric complexes bind to important regulatory sites at erythroid genes, and at the β-globin locus, Ldb1 facilitates long-range promoter–enhancer interactions that are necessary for transcription (Xu et al., 2003; Song et al., 2007). Together, these results suggest that Ldb1 complexes may represent an important instrument for activating erythroid-specific gene transcription during development. Supporting this idea, Lmo2, Gata-1, and Scl are each essential for erythropoiesis suggesting that these proteins function cooperatively (Pevny et al., 1991; Warren et al., 1994; Robb et al., 1995, 1996; Shivdasani et al., 1995; Porcher et al., 1996; Schlaeger et al., 2005).
In this study, we examined the role of Ldb1 in erythroid development by evaluating the impact of ldb1 deletion on erythropoiesis using both conventional and conditional ldb1-deficient mice. Our results reveal an essential and continuous role for Ldb1 in both primitive and definitive erythropoiesis as well as in adult megakaryopoiesis. Short hairpin (sh) RNA–mediated knockdown of Ldb1 resulted in the down-regulation of multiple erythroid/megakaryocyte-specific genes as well as genes important for erythrocyte survival. These findings represent the first comprehensive demonstration of an in vivo role for Ldb1 in erythropoiesis and provide strong support for the idea that an Ldb1-nucleated multiprotein complex serves as a primary mechanism through which Gata-1 exerts its positive regulatory function in erythroid gene transcription.
Ldb1 expression in the hematopoietic lineage
To examine Ldb1 expression in the hematopoietic lineage, adult bone marrow and fetal liver cells were stained intracellularly with affinity-purified polyclonal Ldb1 antisera. FACS analysis revealed that Ldb1 levels are highest in lineagelo/−Sca-1+c-kit+ (LSK) cells (Fig. S1 A), which are known to contain hematopoietic progenitors including HSCs (Ikuta and Weissman, 1992; Morrison et al., 1995). Indeed, in a separate study we found that Ldb1 is critical and continuously required for HSC maintenance (unpublished data). Slightly lower levels of Ldb1 were detected in lineage-committed progenitor populations (common myeloid progenitors [CMPs], megakaryocyte-erythroid progenitors [MEPs], and granulocyte-macrophage progenitors [GMPs]; Fig. S1 A). Interestingly, Ldb1 was also expressed at all stages of erythroid development but was strongly down-regulated in mature myeloid (Gr1+) and lymphoid (B and T) cells (Fig. S1, B and C), suggesting that Ldb1 may also have an important and specific function in erythropoiesis (Fig. S1 C).
Defective primitive erythropoiesis in the absence of Ldb1
It was reported previously that benzidine-positive cells are undetectable in ldb1−/− yolk sacs, suggesting absent or defective primitive erythropoiesis (Mukhopadhyay et al., 2003). In agreement with this observation, in vitro–cultured embryoid bodies derived from ldb1−/− ES cells did not generate erythroid lineage cells, although myeloid lineage cells could be generated in the absence of Ldb1 (Fig. S2 A). Mesoderm/hemangioblast marker genes and genes involved in Ldb1 complex formation (lmo2, scl, gata2, and gata1) were expressed in day 5 ldb1−/− embryoid bodies, but no expression of erythroid-specific genes was detectable at any time point analyzed (Fig. S2, B and C; and not depicted). Consistent with these data, there was no evidence of blood formation in E9 ldb1−/− embryos (Fig. 1 A, left). E9 ldb1−/− yolk sac blood islands contained extremely low numbers of cells (Fig. 1 A, middle) that included rare myeloid blasts but no erythroblasts (Fig. 1 A, right). To evaluate the differentiation potential of progenitor cells in ldb1−/− yolk sacs, single cell suspensions from E9 yolk sacs were cultured in vitro in hematopoietic differentiation medium. Cells from E9 ldb1−/− yolk sacs generated ~10-fold fewer total colonies than cells from control yolk sacs (Fig. 1 B and not depicted). In addition, although control yolk sac cells gave rise to both erythroid and nonerythroid colonies that were apparent by day 6 of culture, ldb1−/− yolk sac cells generated only nonerythroid colonies consisting of myeloid blasts or mature macrophages that were apparent only after 10–14 d of culture (Fig. 1, B and C and not depicted). Together, these results demonstrate that hematopoietic specification is impaired and primitive erythropoiesis is abrogated in the absence of ldb1.
Figure 1.
Figure 1.
ldb1 is required for primitive erythropoiesis. (A) E9.0 embryos were photographed, paraffin embedded, and sectioned for H&E staining. Left, E9.0 ldb1+/+ and ldb1−/− embryos from an ldb1+/− × ldb1+/− mating (more ...)
Ldb1 is required for definitive fetal erythropoiesis
To examine the role of Ldb1 in definitive erythropoiesis, we used a conditional deletion allele of ldb1 (ldb1fl) generated in ES cells by homologous recombination (Suleiman et al., 2007). Although ldb1−/− mice die between E9 and E10, Ldb1fl/fl mice were viable and fertile and exhibited no hematopoietic defects (unpublished data). Cre-recombinase–mediated deletion of the ldb1fl alleles in oocytes recapitulated the early embryonic lethality observed in ldb1−/− mice (unpublished data). Because our results indicated that Ldb1 was required for normal hematopoietic specification and primitive erythropoiesis, we generated mice in which conditional deletion of ldb1 was mediated by the tyrosine kinase with immunoglobulin and epidermal growth factor homology domains 2 (Tie2) Cre transgene (Kisanuki et al., 2001). In a previous study, it was shown that HSCs are generated in normal numbers and primitive erythropoiesis is partially rescued in Tie2Cre sclfl/fl embryos but that Tie2Cre-mediated gene deletion occurs in fetal liver hematopoietic progenitor cells that give rise to definitive erythrocytes (Schlaeger et al., 2005).
To increase the probability that ldb1 would be completely deleted after Cre expression, one Ldb1 allele was deleted in the germline to generate ldb1+/Δ mice. Tie2Cre ldb1+/Δ mice were then crossed with ldb1fl/fl mice to generate Tie2Cre ldb1fl/Δ embryos. Tie2Cre-mediated deletion of the ldbfl allele in fetal liver cells was confirmed by PCR of genomic DNA (Fig. S3 C). Tie2Cre ldb1fl/Δ embryos developed normally through E12. However, by E12.5, all Tie2Cre ldb1fl/Δ embryos exhibited widespread hemorrhage and edema (Fig. S3 A). Fetal liver size and cellularity were markedly decreased in E11.5–14.5 Tie2Cre ldb1fl/Δ mice (Fig. S3, A and B) and no embryos survived beyond E14.5.
EryPs were detected in the blood of all E12.5 Tie2Cre ldb1fl/Δ embryos; however, a maturation defect was apparent from the high percentage of mitotic and basophilic cells and the high frequency of immature erythroid blasts (Fig. 2 A). This phenotype was strikingly similar to that observed in E12.5 Tie2Cre sclfl/fl mice (Schlaeger et al., 2005). The reduced cellularity in Tie2Cre ldb1fl/Δ fetal livers was due primarily to low numbers of erythroid (Ter119+) cells (Fig. 2 B) and was most obvious on E13.0 and thereafter, when the definitive erythroid pool was rapidly expanding in control embryos but not in Tie2Cre Ldb1fl/Δ embryos (Fig. 2 C and Fig. S3 B). Importantly, although the total number of fetal liver cells was decreased in E12.5 Tie2Cre ldb1fl/Δ mice, the number of LSKs was normal at this time point indicating that the erythropoietic defects were not secondary to HSC depletion (Fig. 2 B). Analysis of downstream populations revealed a reduction in LinSca1c-kit+ (LK) fetal liver cells in Tie2Cre ldb1fl/Δ mice, reflecting a marked decrease in the number of MEP (Fig. 2, B and C). In contrast, the number of CMP and GMP fetal liver LK cells was only slightly reduced in E12.5 Tie2Cre ldb1fl/Δ mice, pointing to an early erythroid-specific defect (Fig. 2, B and C). Immature CD71hiTer119low–med proerythroblasts and total Ter119+ cells were also strongly reduced in Tie2Cre ldb1fl/Δ embryos (Fig. 2, B and C).
Figure 2.
Figure 2.
ldb1 is required for definitive fetal erythropoiesis. (A) Giemsa-stained peripheral blood from E12.5 Tie2Cre ldb+/fl and Tie2Cre ldbfl/Δ embryos. Bars, 50 µm. Original magnification, 400×. One representative of three experiments (more ...)
To evaluate the developmental potential of E12.5 Tie2Cre ldb1fl/Δ fetal liver cells, we next performed in vitro methylcellulose progenitor assays. After 8 d of culture, colonies were identified by visual inspection and enumerated. The number of erythroid colonies originating from Tie2Cre Ldb1fl/Δ fetal liver cells was strongly reduced relative to controls (Fig. 2, D and E). In addition, erythroid colonies from Tie2Cre ldb1fl/Δ mice were derived almost exclusively from EryP–colony forming cells (CFCs; Fig. 2 E). In contrast, most erythroid colonies from control fetal livers were derived from definitive burst forming unit–erythroid (BFU-E) progenitors (Fig. 2, D and E; and not depicted). The near absence of definitive BFU-E colonies in Tie2Cre Ldb1fl/Δ fetal liver cultures is consistent with the reduced number of fetal liver erythroid progenitors (MEPs; Fig. 2, B and C). In contrast, the number of nonerythroid CFU-macrophage (M) and CFU-GM progenitors were not significantly reduced in Tie2Cre ldb1fl/Δ fetal livers, identifying a selective requirement for ldb1 in erythroid development (Fig. 2, D and E).
Ldb1 is continuously required for adult erythropoiesis and megakaryopoiesis
To determine if Ldb1 is also required for adult erythropoiesis, we generated Mx1Cre ldb1fl/fl mice so that ldb1 deletion could be induced by injection of polyinosinic-polycytidylic acid (pI:pC; Kühn et al., 1995). As shown in Fig. 3 A, most Mx1Cre ldb1fl/fl mice, but not control ldb1fl/fl mice, died within 20 d of pI:pC injection. As reported previously, injection of pI:pC causes a transient anemia (Hall et al., 2003), and this was observed in both control and Mx1Cre Ldb1fl/fl mice (Fig. 3 B). However, although the hematocrit normalized 14 d after pI:pC injection in control mice, the hematocrit continued to decline in Mx1Cre ldb1fl/fl mice (Fig. 3 B). The total number of bone marrow cells was also dramatically decreased in Mx1Cre ldb1fl/fl mice after pI:pC-mediated Ldb1 deletion (unpublished data). Similar to Tie2Cre ldb1fl/Δ mice, Linlo/−Sca1c-kithiCD34loFcγRlo MEP populations, as well as CD71+Ter119+erythroblasts, were significantly reduced in pI:pC-treated Mx1Cre ldb1fl/fl mice (Fig. 3 C and Fig. S4 A). BFU-E and mixed (erythroid/myeloid) colonies were virtually absent in day 8 methylcellulose cultures of bone marrow cells from pI:pC-treated Mx1Cre Ldb1fl/fl mice (Fig. S4, B and C). Similar to the results obtained with Tie2Cre ldb1fl/Δ fetal liver cells, granulocyte/macrophage colony formation was much less affected by inactivation of ldb1 in adult bone marrow cells (Fig. S4 C).
Figure 3.
Figure 3.
Ldb1 is continuously required for erythropoiesis and megakaryopoiesis in adults. (A) Survival plot of adult MxCre ldb1fl/fl mice (n = 8) and control ldb1fl/fl mice (n = 6) after repeated pI:pC injection (arrows). (B) Hematocrits of MxCre ldb1fl/fl and (more ...)
FACS analysis of the few CD71+Ter119+erythroblasts present in Mx1Cre Ldb1fl/fl mice after pI:pC-induced deletion of ldb1 revealed an increase in the percentage of apoptotic (annexin V+) cells as well as a reduced percentage of cycling cells, indicating a requirement for Ldb1 in cell survival (Fig. 3 C and Fig. S4 A). To determine if Ldb1 is also important for megakaryocyte survival, sternal sections were obtained from pI:pC-treated Mx1Cre ldb1fl/fl and control ldb1fl/fl mice and stained with hematoxylin and eosin (H&E). Strikingly, as early as 8 d after pI:pC injection, no megakaryocytes were detectable in sternum sections from pI:pC-treated Mx1Cre ldb1fl/fl mice, pointing to a critical role for Ldb1 in megakaryocyte survival (Fig. 3 D). In agreement with this finding, platelet counts in the peripheral blood of Mx1Cre ldb1fl/fl mice were markedly reduced relative to control ldb1fl/fl mice 8 d after pI:pC injection (Fig. 4 B).
Figure 4.
Figure 4.
Ldb1 complexes regulate expression of erythroid, megakaryocytic, and prosurvival genes. Stable clones of MEL cells expressing ldb1 shRNA or control shRNA were treated with 1.5% DMSO to induce erythroid differentiation. Total RNA was isolated at the indicated (more ...)
Ldb1 is required for the expression of erythroid, megakaryocyte, and prosurvival genes
To evaluate the impact of Ldb1 down-regulation on the expression of erythroid- and megakaryocytic-specific genes, we analyzed gene expression in a Friend mouse erythroleukemia (MEL) cell line expressing a stable construct encoding ldb1 shRNA (Song et al., 2007). Differentiation of the MEL cell line was stimulated by DMSO, which has been shown to induce the expression of erythroid- and megakaryocyte-specific transcripts (Friend et al., 1973). As shown in Fig. 4 A, ldb1 transcripts were reduced by 20–50% in both uninduced and DMSO-induced Ldb1 shRNA MEL cells. Interestingly, knockdown of ldb1 strongly inhibited the induced expression of several erythroid genes including α- and β-globin, epb4.2, slc4α1, and alas2 (Fig. 4 A). In addition, expression of the megakaryocyte-specific transcript itga2b was also markedly decreased (Fig. 4 A). These results confirm and extend previous studies supporting a critical requirement for Ldb1 in erythroid gene expression (Xu et al., 2003; Anguita et al., 2004; Lahlil et al., 2004; Song et al., 2007). The dramatic increase in apoptotic erythroblasts after in vivo deletion of ldb1 (Fig. 3 C) also prompted us to examine the effect of ldb1 knockdown on the expression of erythroid prosurvival factors. As shown in Fig. 4 B, expression of three prosurvival genes, epor, bcl-xl, and sox6, was also significantly decreased in ldb1 shRNA MEL cells, especially at later time points in cell culture when these genes were highly induced in control cells (Fig. 4 B). These results indicate that Ldb1 protein complexes regulate the expression of prosurvival as well as erythroid- and megakaryocyte-specific genes.
In the present study, we relate data demonstrating a critical, continuous, and specific role for Ldb1 in both erythropoiesis and megakaryopoiesis. These results are consistent with the high expression of Ldb1 in erythroid progenitors (Fig. S1) and with the observation that deletion of ldb1 leads to a severe developmental block at the common megakaryocyte/erythroid progenitor stage (Fig. 2 C and Fig. 3 C). Deletion of ldb1 severely impacted the erythroid/megakaryocyte lineages but had little effect on the development of myeloid cells. Using B cell– or T cell–specific Cre transgenes, we also found no evidence of a requirement for ldb1 in lymphocyte development (unpublished data). A similar nonmandatory role for lmo2 in T cell development was also demonstrated (McCormack et al., 2003).
Our results indicate that an important function of Ldb1 during erythropoiesis is to induce the expression of lineage-specific and prosurvival genes, presumably via its documented role as a key subunit of Ldb1/Lmo2/Scl/E2A/Gata-1 multimeric complexes (Fig. 4). Ldb1 nucleated complexes have been shown to regulate the expression of several erythroid genes including α- and β- globin, epb4.2, and gypA (Xu et al., 2003; Anguita et al., 2004; Lahlil et al., 2004; Song et al., 2007). In addition, genome-wide profiling studies have detected Ldb1 at most Gata-1–bound DNA elements in erythroid cell lines, suggesting that Ldb1 complexes represent a major instrument for Gata-1–mediated gene activation (Tripic et al., 2009; Soler et al., 2010). In this paper, we provide evidence that down-regulation of Ldb1 severely impairs the induced expression of multiple erythroid- and/or megakaryocyte-specific genes in erythroleukemia cells. Interestingly, the expression of genes encoding other Ldb1 complex subunits, including lmo2, gata-1, and scl, was not as severely affected by down-regulation of ldb1, indicating that failure to assemble functional Ldb1 complexes, rather than reduced expression of Ldb1 complex subunits, is responsible for the reduction in erythroid gene expression (Fig. 4). In summary, these results establish an essential function for Ldb1 during erythrocyte and megakaryocyte development and survival and suggest that Ldb1-nucleated complexes represent an important mechanism by which Gata-1 activates gene transcription in these lineages.
Mice.
Tie2Cre and Mx1Cre transgenic mice were purchased from The Jackson Laboratory. All mice were bred and maintained in a National Institutes of Health (NIH) Research Animal Facility in accordance with the specifications of the Association for Assessment and Accreditation of Laboratory Animal Care. Mouse protocols were approved by the NIH Animal Care and Use Committee.
Ldb1 antibody and Ldb1 intracellular staining.
Polyclonal rabbit anti-sera were raised against Ldb1 peptide MLDRDVGPTPMYPPTYLEPC-amide, affinity purified, and conjugated with Alexa Fluor 647 (A20186; Invitrogen). Purified rabbit IgG (AB-105-C; R&D Systems) conjugated in the same way served as background control. Freshly isolated single cell suspensions were surface stained, fixed with 2% formaldehyde, permeabilized with 0.5% Triton X-100 (Bio-Rad Laboratories) in PBS, stained with Alexa Fluor 647–conjugated rabbit anti-Ldb1 or rabbit IgG, and analyzed by flow cytometry.
Embryonic stem cell (ESC) lines.
The generation of ldb1+/− ESCs (Mukhopadhyay et al., 2003), ldb1−/− ESCs (Hwang et al., 2008), and ldb1fl ESCs (Suleiman et al., 2007) has been described previously.
ESC culture and embryoid body formation.
Undifferentiated ESCs were cultured in modified DME (Invitrogen) containing 15% FCS and LIF on mitomycin-treated embryonic fibroblast feeders. To generate embryoid bodies, ESC cultures were trypsinized until 5–10 cell clusters were formed. Trypsinization was stopped by addition of 10 ml IMDM medium containing 10% fetal calf serum and cells were incubated for 45 min at 37°C to allow reattachment of embryonic fibroblasts. ESCs were transferred to 10-cm bacterial Petri dishes and incubated in IMDM plus 15% FCS for 3–6 d in the presence of 40 ng/ml SCF and observed for the formation of embryoid bodies. Embryoid bodies generated in the primary culture were harvested by gravity sedimentation and plated in secondary methylcellulose cultures containing 50 ng/ml of recombinant mouse (rm) SCF, 10 ng/ml rm IL-3, and 10 ng/ml rh IL-6 or 50 ng/ml rm SCF and 3 U/ml rh Epo (STEMCELL Technologies Inc.).
CFC assays.
Assays for hematopoietic progenitors in fetal liver or adult bone marrow were performed by culturing enumerated cells in methylcellulose-based IMDM medium containing 3 U/ml of recombinant human (rh) Epo, 50 ng/ml rm SCF, 10 ng/ml rm IL-3, and 10 ng/ml rh IL-6 (STEMCELL Technologies Inc.). For cultures of fetal liver cells and bone marrow cells, 2.5 × 104–105 cells were plated in duplicate and scored for colony formation at day 8. For yolk sac cultures, single cell suspensions of E9 yolk sacs were made, divided in half, and plated in duplicate.
Flow cytometry and cell cycle analysis.
Conjugated antibodies, including mouse and hamster IgG isotype controls, were purchased from BD or eBioscience. The lineage marker (Lin) mixture for fetal liver cells included the following biotinylated antibodies: CD3-ε (145-2C11), CD4 (GK1.5), CD8-α (53–6), CD8-β (53–5.8), TCR-β (H57-597), TCR-γδ (GL3), CD19 (1D3), B220 (RA3-6B2), Gr1 (RB6-8C5), Ter119, CD49b (Dx5), and NK1.1 (PK136). Lin mixture for adult bone marrow cells included all of these plus Mac-1 (M1/70). Other conjugated antibodies used for surface staining included: CD34 (RAM34), CD43 (S7), CD71 (C2), c-kit (2B8), Sca1 (D7), and FcγIII/IIR (2.4G2). Biotinylated primary antibodies were detected by incubation of antibody-coated cells with streptavidin-PerCP-Cy5.5 or APC-Cy7 in a two step staining procedure. Percentage of apoptotic cells was determined by annexin V (BD) staining according to the manufacturer’s instructions. For cell cycle analysis, cells were surface stained, fixed in 2% formaldehyde, permeabilized in 0.1% NP-40, and then stained with DAPI (Invitrogen). Data were acquired with a FACSCalibur or LSR II flow cytometer and analyzed with FlowJo software (Tree Star, Inc.).
RT-PCR and quantitative RT-PCR.
The MEL cell line expressing ldb1 shRNA has been described previously (Song et al., 2007). For gene expression studies, total cell RNA was isolated using PicoPure RNA isolation kit (Arcturus), and 100 ng of each RNA sample was reverse transcribed using SuperScript first-strand synthesis system (Invitrogen) and assayed by RT-PCR. Transcript quantification was performed with a LightCycler 480 (Roche). Duplicates were run for each sample in a 96-well plate. β-Actin was used as the endogenous reference gene. All quantitative RT-PCR reactions were run in three independent experiments. The relative quantification method was used, with the ratio of the mRNA level for the gene of interest normalized to the level of β-actin and the mean of control bone marrow samples as the calibrator value. The specificity of the products was confirmed based on melting curves and electrophoresis.
Genotyping and deletion analysis of Tie2Cre ldbfl/Δ mice and Mx1Cre ldbfl/fl mice.
PCR genotyping of Tie2Cre Ldbfl/Δ mice and Mx1Cre Ldbfl/fl mice was performed on tail DNA. Primers used for detection of the Cre transgene were 5′-CGATGCAACGAGTGATGAGG-3′ and 5′-GACTTGCTGTCACTTGGTCGT-3′. For Tie2Cre Ldbfl/Δ mice, a combination of the following three oligonucleotide primers were used to detect the wild-type Ldb1, the Ldb1fl, and the Cre-mediated deleted (LdbΔ) alleles: Ldb1S 5′-CAGCAAACGGAGGAAACGGAAGATGTCAG-3′, Ldb1AS 5′-CTTATGTGAC­CACAGCCATGC­ATGCATGTG-3′, and Ldb1A 5′-TCAGGCTGGCCTTTAAACCTAA-3′. Ldb1S-Ldb1AS amplified a 320-bps wild-type allele fragment and 445-bps floxed allele fragment. Ldb1A-LdbAS amplified a 390-bps Ldb1 Cre-mediated recombination allele fragment. For Mx1Cre ldb1fl/fl mice, a combination of the following three oligonucleotide primers were used to detect the wild-type Ldb1, the Ldb1fl, and the Cre-mediated deleted (ldbΔ) alleles: Ldb1A 5′-TCAGGCTGGCCTTTAAACCTAA-3′, Ldb1B 5′-TGGGACTACAAGGCTGAGAACA-3′, and Ldb1C 5′-TGGCTGAGCTTATGTGACCA-3′. Ldb1B-Ldb1C amplified a 458-bp wild-type allele fragment and a 534-bp floxed allele fragment. Ldb1A-LdbC amplified a 342-bp Ldb1 deleted allele fragment.
Conditional inactivation of Ldb1 in adult mice.
To inactivate ldb1 in adult hematopoietic cells, 250 µl pI:pC (1 mg/ml; GE Healthcare) was injected intraperitoneally into each mouse on days 1, 3, and 5 (the day of the first injection was designated day 1). Mice were sacrificed on day 8 unless otherwise noted. Cells obtained from bone marrow or spleen were either analyzed directly or cultured in methylcellulose to analyze their colony forming potential.
Online supplemental material.
Fig. S1 shows Ldb1 expression in hematopoietic cells. Fig. S2 shows impaired erythroid developmental potential of ldb1−/− ESCs. Fig. S3 shows defective erythropoiesis in Tie2Cre ldbfl/Δ embryos. Fig. S4 shows that Ldb1 is continuously required for survival and expansion of erythroblasts in adults. Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20100504/DC1.
Acknowledgments
We thank Heiner Westphal for providing mouse and cell lines and Dalal El-Khoury and Tsadok Cohen for technical support.
This research was supported by the Intramural Research Program of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and National Institutes of Diabetes and Digestive and Kidney Diseases.
The authors have no conflicting financial interests.
Footnotes
Abbreviations used:
BFU-Eburst forming unit–erythroid
CFCcolony forming cell
CMPcommon myeloid progenitor
EryPprimitive erythrocyte
ESCembryonic stem cell
GMPgranulocyte-macrophage progenitor
HSChematopoietic stem cell
Ldb1Lim domain binding protein 1
LKLinSca1c-kit+
LSKlineagelo/−Sca-1+c-kit+
MELmouse erythroleukemia
MEPmegakaryocyte-erythroid progenitor
pI:pCpolyinosinic-polycytidylic acid

  • Anguita E., Hughes J., Heyworth C., Blobel G.A., Wood W.G., Higgs D.R. 2004. Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2. EMBO J. 23:2841–2852. doi: 10.1038/sj.emboj.7600274. [PubMed] [Cross Ref]
  • Baumann R., Dragon S. 2005. Erythropoiesis and red cell function in vertebrate embryos. Eur. J. Clin. Invest. 35:2–12. doi: 10.1111/j.1365-2362.2005.01524.x. [PubMed] [Cross Ref]
  • Friend C., Scher W., Preisler H.D., Holland J.G. 1973. Studies on erythroid differentiation of Friend virus-induced murine leukemic cells. Bibl. Haematol. 39:916–923. [PubMed]
  • Hall M.A., Curtis D.J., Metcalf D., Elefanty A.G., Sourris K., Robb L., Gothert J.R., Jane S.M., Begley C.G. 2003. The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12. Proc. Natl. Acad. Sci. USA. 100:992–997. doi: 10.1073/pnas.0237324100. [PubMed] [Cross Ref]
  • Hwang M., Gorivodsky M., Kim M., Westphal H., Geum D. 2008. The neuronal differentiation potential of Ldb1-null mutant embryonic stem cells is dependent on extrinsic influences. Stem Cells. 26:1490–1495. doi: 10.1634/stemcells.2007-1099. [PubMed] [Cross Ref]
  • Ikuta K., Weissman I.L. 1992. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc. Natl. Acad. Sci. USA. 89:1502–1506. doi: 10.1073/pnas.89.4.1502. [PubMed] [Cross Ref]
  • Johnson K.D., Boyer M.E., Kang J.A., Wickrema A., Cantor A.B., Bresnick E.H. 2007. Friend of GATA-1-independent transcriptional repression: a novel mode of GATA-1 function. Blood. 109:5230–5233. doi: 10.1182/blood-2007-02-072983. [PubMed] [Cross Ref]
  • Kim S.I., Bresnick E.H. 2007. Transcriptional control of erythropoiesis: emerging mechanisms and principles. Oncogene. 26:6777–6794. doi: 10.1038/sj.onc.1210761. [PubMed] [Cross Ref]
  • Kisanuki Y.Y., Hammer R.E., Miyazaki J., Williams S.C., Richardson J.A., Yanagisawa M. 2001. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 230:230–242. doi: 10.1006/dbio.2000.0106. [PubMed] [Cross Ref]
  • Kühn R., Schwenk F., Aguet M., Rajewsky K. 1995. Inducible gene targeting in mice. Science. 269:1427–1429. doi: 10.1126/science.7660125. [PubMed] [Cross Ref]
  • Lahlil R., Lécuyer E., Herblot S., Hoang T. 2004. SCL assembles a multifactorial complex that determines glycophorin A expression. Mol. Cell. Biol. 24:1439–1452. doi: 10.1128/MCB.24.4.1439-1452.2004. [PMC free article] [PubMed] [Cross Ref]
  • McCormack M.P., Forster A., Drynan L., Pannell R., Rabbitts T.H. 2003. The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development. Mol. Cell. Biol. 23:9003–9013. doi: 10.1128/MCB.23.24.9003-9013.2003. [PMC free article] [PubMed] [Cross Ref]
  • Morrison S.J., Uchida N., Weissman I.L. 1995. The biology of hematopoietic stem cells. Annu. Rev. Cell Dev. Biol. 11:35–71. doi: 10.1146/annurev.cb.11.110195.000343. [PubMed] [Cross Ref]
  • Mukhopadhyay M., Teufel A., Yamashita T., Agulnick A.D., Chen L., Downs K.M., Schindler A., Grinberg A., Huang S.P., Dorward D., Westphal H. 2003. Functional ablation of the mouse Ldb1 gene results in severe patterning defects during gastrulation. Development. 130:495–505. doi: 10.1242/dev.00225. [PubMed] [Cross Ref]
  • Palis J., Robertson S., Kennedy M., Wall C., Keller G. 1999. Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development. 126:5073–5084. [PubMed]
  • Pevny L., Simon M.C., Robertson E., Klein W.H., Tsai S.F., D’Agati V., Orkin S.H., Costantini F. 1991. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature. 349:257–260. doi: 10.1038/349257a0. [PubMed] [Cross Ref]
  • Porcher C., Swat W., Rockwell K., Fujiwara Y., Alt F.W., Orkin S.H. 1996. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell. 86:47–57. doi: 10.1016/S0092-8674(00)80076-8. [PubMed] [Cross Ref]
  • Robb L., Lyons I., Li R., Hartley L., Köntgen F., Harvey R.P., Metcalf D., Begley C.G. 1995. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc. Natl. Acad. Sci. USA. 92:7075–7079. doi: 10.1073/pnas.92.15.7075. [PubMed] [Cross Ref]
  • Robb L., Elwood N.J., Elefanty A.G., Köntgen F., Li R., Barnett L.D., Begley C.G. 1996. The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J. 15:4123–4129. [PubMed]
  • Schlaeger T.M., Mikkola H.K., Gekas C., Helgadottir H.B., Orkin S.H. 2005. Tie2Cre-mediated gene ablation defines the stem-cell leukemia gene (SCL/tal1)-dependent window during hematopoietic stem-cell development. Blood. 105:3871–3874. doi: 10.1182/blood-2004-11-4467. [PubMed] [Cross Ref]
  • Shivdasani R.A., Mayer E.L., Orkin S.H. 1995. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature. 373:432–434. doi: 10.1038/373432a0. [PubMed] [Cross Ref]
  • Soler E., Andrieu-Soler C., de Boer E., Bryne J.C., Thongjuea S., Stadhouders R., Palstra R.J., Stevens M., Kockx C., van Ijcken W., et al. 2010. The genome-wide dynamics of the binding of Ldb1 complexes during erythroid differentiation. Genes Dev. 24:277–289. doi: 10.1101/gad.551810. [PubMed] [Cross Ref]
  • Song S.H., Hou C., Dean A. 2007. A positive role for NLI/Ldb1 in long-range beta-globin locus control region function. Mol. Cell. 28:810–822. doi: 10.1016/j.molcel.2007.09.025. [PMC free article] [PubMed] [Cross Ref]
  • Suleiman H., Heudobler D., Raschta A.S., Zhao Y., Zhao Q., Hertting I., Vitzthum H., Moeller M.J., Holzman L.B., Rachel R., et al. 2007. The podocyte-specific inactivation of Lmx1b, Ldb1 and E2a yields new insight into a transcriptional network in podocytes. Dev. Biol. 304:701–712. doi: 10.1016/j.ydbio.2007.01.020. [PubMed] [Cross Ref]
  • Tripic T., Deng W., Cheng Y., Zhang Y., Vakoc C.R., Gregory G.D., Hardison R.C., Blobel G.A. 2009. SCL and associated proteins distinguish active from repressive GATA transcription factor complexes. Blood. 113:2191–2201. doi: 10.1182/blood-2008-07-169417. [PubMed] [Cross Ref]
  • Wadman I.A., Osada H., Grütz G.G., Agulnick A.D., Westphal H., Forster A., Rabbitts T.H. 1997. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J. 16:3145–3157. doi: 10.1093/emboj/16.11.3145. [PubMed] [Cross Ref]
  • Warren A.J., Colledge W.H., Carlton M.B., Evans M.J., Smith A.J., Rabbitts T.H. 1994. The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell. 78:45–57. doi: 10.1016/0092-8674(94)90571-1. [PubMed] [Cross Ref]
  • Welch J.J., Watts J.A., Vakoc C.R., Yao Y., Wang H., Hardison R.C., Blobel G.A., Chodosh L.A., Weiss M.J. 2004. Global regulation of erythroid gene expression by transcription factor GATA-1. Blood. 104:3136–3147. doi: 10.1182/blood-2004-04-1603. [PubMed] [Cross Ref]
  • Xu Z., Huang S., Chang L.S., Agulnick A.D., Brandt S.J. 2003. Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation. Mol. Cell. Biol. 23:7585–7599. doi: 10.1128/MCB.23.21.7585-7599.2003. [PMC free article] [PubMed] [Cross Ref]
Articles from The Journal of Experimental Medicine are provided here courtesy of
The Rockefeller University Press